Daniel M. Halperin, MD

Specialty: Medical Oncology

Winship Cancer Institute of Emory University

Multidisciplinary NET treatment program

1365 Clifton Road NE
Altlanta , Georgia

Patient scheduling: 404-778-1900

Daniel M. Halperin, MD is actively involved in neuroendocrine cancer research.

Research interests:

epidemiology, immunotherapy, radioligands, experimental therapeutics

Subspecialty areas:

• Lung NETs
• GI NETs
• Pancreatic NETs
• Pheochromocytoma/Paraganglioma
• Liver metastasis
• Nuclear medicine

NET-related professional association memberships:

• North American Neuroendocrine Tumor Society (NANETS)
• NCCN NET Guidelines Panel Member

Leadership role(s):

• North American Neuroendocrine Tumor Society (NANETS)
• NETRF, NANETS

NETRF Presentations by Daniel Halperin, MD

Daniel Halperin, MD

NET Symptoms and Treatments Watch Video

Daniel Halperin, MD

Immunotherapy & Clinical Trials Watch Video

NETRF news stories including Daniel Halperin, MD

Immunotherapy Update: What We’ve Learned

Immunotherapy has been called one of the most significant advances in cancer in decades. While

NETRF Seed Funding Helps Grow the Field

Two NETRF-funded researchers received Career Development Awards at the 2018 annual meeting of the American

Study shows rising rates of NET incidence, prevalence, and survival

Study shows rising incidence and prevalence of NETs. Plus people living longer with neuroendocrine cancer. This means more people living with NETs.